Pages that link to "Q90482548"
Jump to navigation
Jump to search
The following pages link to Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro (Q90482548):
Displaying 50 items.
- Insights from nanomedicine into chloroquine efficacy against COVID-19 (Q90591389) (← links)
- Chloroquine and COVID-19, where do we stand? (Q90685577) (← links)
- Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future (Q90712071) (← links)
- A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 (Q90750837) (← links)
- COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? (Q91715293) (← links)
- Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes (Q91722563) (← links)
- Harnessing Innate Immunity to Eliminate SARS-CoV-2 and Ameliorate COVID-19 Disease (Q91802154) (← links)
- Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic (Q91809009) (← links)
- Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society (Q91823733) (← links)
- Drug repositioning an alternative for the treatment of coronavirus COVID-19 (Q91828672) (← links)
- Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review (Q91851271) (← links)
- Cardiovascular Considerations in Treating Patients with Coronavirus (COVID-19) (Q91859258) (← links)
- Care of the Pregnant Woman with COVID-19 in Labor and Delivery: Anesthesia, Emergency cesarean delivery, Differential diagnosis in the acutely ill parturient, Care of the newborn, and Protection of the healthcare personnel (Q91863542) (← links)
- Does Hydroxychloroquine Combat COVID-19? A Timeline of Evidence (Q91864744) (← links)
- Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling approach for effective drug repurposing (Q91887557) (← links)
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study (Q91916510) (← links)
- [Coronavirus: from common cold to severe pulmonary failure] (Q91940937) (← links)
- Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19 (Q91945609) (← links)
- COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies (Q91945830) (← links)
- Antiviral treatment of COVID-19 (Q91953851) (← links)
- Blocking drug-induced autophagy with chloroquine in HCT-116 colon cancer cells enhances DC maturation and T cell responses induced by tumor cell lysate (Q91991223) (← links)
- Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19 (Q92016886) (← links)
- Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions (Q92031061) (← links)
- Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base (Q92032072) (← links)
- American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in (Q92037151) (← links)
- Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties (Q92043294) (← links)
- CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement (Q92053974) (← links)
- Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection (Q92082129) (← links)
- Chloroquine reduces Th17 cell differentiation by stimulating T-bet expression in T cells (Q92095239) (← links)
- Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic (Q92119967) (← links)
- Understanding SARS-CoV-2: Genetic Diversity, Transmission and Cure in Human (Q92131268) (← links)
- COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country (Q93160359) (← links)
- Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance (Q93166070) (← links)
- Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19 (Q93190302) (← links)
- Current status of potential therapeutic candidates for the COVID-19 crisis (Q93223160) (← links)
- Incidence of coronavirus disease (COVID-19) and countries affected by malarial infections (Q93223318) (← links)
- SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies? (Q93223371) (← links)
- Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2 (Q93240693) (← links)
- Covid-19 treatment update: follow the scientific evidence (Q93250708) (← links)
- COVID-19 in Children: Clinical Approach and Management (Q93251009) (← links)
- Thoughts on COVID-19 and autoimmune diseases (Q93271979) (← links)
- In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect (Q94446906) (← links)
- Finding the dose for hydroxychloroquine prophylaxis for COVID-19; the desperate search for effectiveness (Q94448007) (← links)
- Internet Searches for Unproven COVID-19 Therapies in the United States (Q94456588) (← links)
- Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety (Q94456661) (← links)
- Response to "Quantitative clinical pharmacology input to SARS-CoV-2 therapeutics should be based on robust data" (Q94457944) (← links)
- Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19 (Q94459179) (← links)
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options (Q94467004) (← links)
- An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications (Q94503705) (← links)
- FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication (Q94506354) (← links)